Intended for diagnosing active pulmonary tuberculosis, the test will use Cere's Nanotrap reagents for enriching target analytes for downstream analysis.
The study suggests Indi's Xpresys test could be useful in physician decision making but raises questions about the extent to which doctors will follow its recommendations.
While the company had previously planned to launch on mass spec, it is using ELISA for the initial version of the test in a bid to bring it to market more quickly.
The test is based on a technology developed by an Amprion co-founder for the amplification of prions.
In a 250-patient cohort, the marker detected pancreatic cancer stages I-IV with specificity and sensitivity of 100 percent.
In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.
An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.
Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.
US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.